Canary Speech Named to TIME’s World’s Top HealthTech Companies 2026 List
News related to:Canary Speech · 1 min read
PROVO, Utah, Sept. 17, 2026 /CourierPR/ -- Canary Speech, a Utah-based AI-powered voice biomarker health tech company, has been included in TIME’s World’s Top HealthTech Companies 2026 list. This recognition, awarded by TIME and Statista Inc., is the second time Canary Speech has been honored with this prestigious accolade.
The World’s Top HealthTech Companies 2026 ranking evaluates companies based on financial performance metrics, reputation analysis, and online engagement. Out of thousands of HealthTech companies reviewed, Canary Speech was among the top 500 for its outstanding performance in these critical areas. The company’s vocal biomarker technology analyzes speech to identify clinically relevant information, helping healthcare organizations detect health conditions earlier and improve patient outcomes.
Henry O'Connell, CEO of Canary Speech, expressed his delight at the recognition.
Canary Speech’s technology is designed to integrate seamlessly into existing healthcare workflows. Through its Canary Ambient™ solution, the company provides real-time voice analysis for clinical, wellness, and safety applications. Canary Ambient™ supports screening and longitudinal monitoring for behavioral, cognitive, and neurological conditions, including depression, anxiety, mild cognitive impairment, Alzheimer's disease, multiple sclerosis, Parkinson's disease, and Huntington's disease. Canary Safety™ offers real-time detection of aggression and violence risk, while Canary Wellness™ helps organizations monitor workforce stress, mood, energy, and burnout.
Canary Speech’s technology is supported by extensive clinical research that examines how changes in voice can provide insights into behavioral, cognitive, and neurological health. The company’s AI-powered platform captures and analyzes speech data, detecting subtle changes that may indicate early signs of mental health and neurological disorders.
The recognition from TIME and Statista Inc. underscores the growing importance of vocal biomarkers in healthcare. Canary Speech’s technology is poised to play a significant role in advancing early detection and intervention in a range of health conditions, ultimately leading to better patient outcomes and more informed healthcare decisions.